CDK8 is a colorectal cancer oncogene that regulates β-catenin activity

Nature

Volumn 455, Issue 7212, 2008, Pages 547-551

  Firestein, Ron ^a,b,d   Bass, Adam J ^a,b,d   Kim, So Young ^a,b,d   Dunn, Ian F ^a,b,d   Silver, Serena J ^d   Guney, Isil ^a,d   Freed, Ellen ^a   Ligon, Azra H ^b   Vena, Natalie ^a   Ogino, Shuji ^a,b   Chheda, Milan G ^a,c,d   Tamayo, Pablo ^d   Finn, Stephen ^b   Shrestha, Yashaswi ^a,d   Boehm, Jesse S ^d   Jain, Supriya ^a   Bojarski, Emeric ^a   Mermel, Craig ^a,d   Barretina, Jordi ^a,d   Chan, Jennifer A ^b,d   Baselga, Jose ^e   Tabernero, Josep ^e   Root, David E ^d   Fuchs, Charles S ^a   Loda, Massimo ^a,b   Shivdasani, Ramesh A ^a,b   Meyerson, Matthew ^a,b,d   Hahn, William C ^a,b,d   more..

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN DEPENDENT KINASE 8; WNT PROTEIN;

CANCER; COMPARATIVE STUDY; DISEASE TREATMENT; ENZYME ACTIVITY; GENE EXPRESSION; HOMINID; INHIBITION; PROTEIN; TUMOR;

ARTICLE; CELL PROLIFERATION; COLORECTAL CANCER; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; PRIORITY JOURNAL;

BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASES; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ONCOGENE PROTEINS; ONCOGENES; RNA INTERFERENCE; TRANSCRIPTION, GENETIC;

EID: 52949111487     PISSN: 00280836     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/nature07179     Document Type: Article

References (33)

1. Bienz, M. & Clevers, H. Linking colorectal cancer to Wnt signaling. Cell 103, 311-320 (2000).
2. Camp, R. L., Chung, G. G. & Rimm, D. L. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nature Med. 8, 1323-1327 (2002).
3. Vogelstein, B. et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319, 525-532 (1988).
4. Conaway, R. C., Sato, S., Tomomori-Sato, C., Yao, T. & Conaway, J. W. The mammalian Mediator complex and its role in transcriptional regulation. Trends Biochem. Sci. 30, 250-255 (2005).
5. Smith, G. et al. Mutations in APC, Kirsten-ras, and p53 - alternative genetic pathways to colorectal cancer. Proc. Natl Acad. Sci. USA 99, 9433-9438 (2002).
6. van de Wetering, M. et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241-250 (2002).
7. Moffat, J. et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124, 1283-1298 (2006).
8. -/- colon carcinoma. Science 275, 1784-1787 (1997).
9. Davidson, G. et al. Casein kinase 1γ couples Wnt receptor activation to cytoplasmic signal transduction. Nature 438, 867-872 (2005).
10. Hino, S., Michiue, T., Asashima, M. & Kikuchi, A. Casein kinase Iε enhances the binding of Dvl-1 to Frat-1 and is essential for Wnt-3a-induced accumulation of β-catenin. J. Biol. Chem. 278, 14066-14073 (2003).
11. Beroukhim, R. et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl Acad. Sci. USA 104, 20007-20012 (2007).
12. Weir, B. A. et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 450, 893-898 (2007).
13. Martin, E. S. et al. Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types. Cancer Res. 67, 10736-10743 (2007).
14. Tsafrir, D. et al. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res. 66, 2129-2137 (2006).
15. Morris E. J. . et al. E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8. Nature doi:10.1038/nature07310 (this issue).
16. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005).
17. Garraway, L. A. et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117-122 (2005).
18. Gold, M. O. & Rice, A. P. Targeting of CDK8 to a promoter-proximal RNA element demonstrates catalysis-dependent activation of gene expression. Nucleic Acids Res. 26, 3784-3788 (1998).
19. Ilyas, M., Tomlinson, I. P., Rowan, A., Pignatelli, M. & Bodmer, W. F. β-Catenin mutations in cell lines established from human colorectal cancers. Proc. Natl Acad. Sci. USA 94, 10330-10334 (1997).
20. Sparks, A. B., Morin, P. J., Vogelstein, B. & Kinzler, K. W. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res. 58, 1130-1134 (1998).
21. Rowan, A. J. et al. APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". Proc. Natl Acad. Sci. USA 97, 3352-3357 (2000).
22. Tassan, J. P., Jaquenoud, M., Leopold, P., Schultz, S. J. & Nigg, E. A. Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C. Proc. Natl Acad. Sci. USA 92, 8871-8875 (1995).
23. Sansom, O. J. et al. Myc deletion rescues Apc deficiency in the small intestine. Nature 446, 676-679 (2007).
24. Murakami, T. et al. Constitutive activation of Wnt/β-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential. Biochem. Biophys. Res. Commun. 288, 8-15 (2001).
25. He, T. C. et al. Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512 (1998).
26. Fryer, C. J., White, J. B. & Jones, K. A. Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol. Cell 16, 509-520 (2004).
27. Yook, J. I. et al. A Wnt-Axin2-GSK3β cascade regulates Snail1 activity in breast cancer cells. Nature Cell Biol. 8, 1398-1406 (2006).
28. Chiang, M. Y. et al. Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1. Mol. Cell. Biol. 26, 6261-6271 (2006).
29. Kolligs, F. T., Hu, G., Dang, C. V. & Fearon, E. R. Neoplastic transformation of RK3E by mutant β-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol. Cell. Biol. 19, 5696-5706 (1999).
30. Boehm, J. S. et al. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 129, 1065-1079 (2007).
31. Beroukhim, R. et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl Acad. Sci. USA 104, 20007-20012 (2007).
32. Damalas, A. et al. Deregulated β-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J. 20, 4912-4922 (2001).
33. Weir, B. A. et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 450, 893-898 (2007).